FindTrial
Sign In

To check the effect and Safety of immunity booster in Healthy Adults for Improvement in Immunity Hair Fall Skin Allergies and Pigmentation

A SingleCenter Randomized DoubleBlind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Skinovate Blueberry immunity booster in Healthy Adults for Improvement in Immunity Hair Fall Skin Allergies and Pigmentation - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098803
Enrollment
40
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Blueberry immunity booster: Placebo (Sugar pill) Under details, please mention the dose - Single Dose frequency route of administration - once a day oral Total duration of such interv

Sponsors

Skinovate Laser Cosmetic Surgery Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Healthy males and females aged 18 60 2 Mild hair fall pigmentation issues or skin allergy history 3 Willingness to comply and provide informed consent

Exclusion criteria

Exclusion criteria: 1 Allergy to study product components 2 Active dermatological systemic disease 3 Pregnant lactating women 4 Recent participation in clinical trials 30 days 5 Use of other hair skin or immunity supplements

Design outcomes

Primary

MeasureTime frame
Evaluate efficacy of Blueberry immunity booster in reducing hair fall compared to placebo after 8 weeks of supplementation.Timepoint: Eight weeks—

Secondary

MeasureTime frame
1 Evaluate improvements in skin allergy symptoms itching redness rashes 2 Assess changes in skin pigmentation using objective and subjective measures 3 Evaluate safety and tolerability of Blueberry immunity booster Timepoint: Eight weeks—

Countries

India

Contacts

Public ContactDr Sonal Shendkar

Skinovate Laser Cosmetic Surgery Center,

drsonal.skinovate@gmail.com09743849130

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026